How a Bedroom Drug Became a BPH Treatment

Watchful waiting is a real, doctor-approved option for mild BPH. See how that works alongside every medication and procedure actually approved for treating it.

Author image

Written by Valerii Vasilevskyi, MD, PhD

Published 28 August 2026

BPH treatment today spans everything from a once-daily pill originally developed for a completely different condition, to same-day office procedures that didn't exist twenty years ago. This piece walks through what's actually approved, an interesting complication one drug class creates for cancer screening, and what doing nothing (on purpose) can look like too.

Looking for treatment options for BPH?

Browse open BPH clinical trials near you! We'll handle the follow-up.

What's approved right now, in plain terms

Alpha-blockers (tamsulosin, alfuzosin, silodosin, doxazosin, terazosin) relax the muscle in the prostate and bladder neck, easing symptoms within days, but they don't shrink the prostate or slow its growth over time.

5-alpha-reductase inhibitors (finasteride, dutasteride) work differently. They block the hormone conversion that drives prostate growth, so they take months to show a benefit, but they can shrink the prostate over time in a way alpha-blockers can't.

Tadalafil (Cialis) is the one that surprises people. Originally approved only for erectile dysfunction, it was approved in October 2011 specifically for BPH symptoms too, and separately for men who have both ED and BPH at once, making it the only medicine with all three of those approvals. It relaxes smooth muscle in a similar way to alpha-blockers, just through a different chemical pathway.

The PSA complication almost no one explains well

5-alpha-reductase inhibitors usually lower your PSA level, roughly cutting it in half. PSA is the blood marker doctors use to help screen for prostate cancer. This isn't dangerous by itself, but your doctor needs to check your PSA before you start the medicine, and know you're taking it whenever they read a PSA test later. Otherwise, a lower number could look reassuring when it isn't, and delay catching something important. The FDA also requires a warning label for this drug class about a possible link to a more aggressive form of prostate cancer. That's worth discussing with your doctor, not a reason to avoid the medicine on your own.

What researchers are studying now

Researchers are also comparing newer in-office procedures against each other, and against traditional surgery, to figure out which one works best for which symptoms and prostate size, instead of treating them as interchangeable. Other studies are testing combinations, like pairing a procedure with a short course of medication, to see if that improves recovery or long-term results compared to either one alone.

Why BPH research keeps refining rather than reinventing

The overlap problem. BPH, ED, and even early prostate cancer screening all intersect in the same office visit for a lot of men, and treatments for one can complicate how doctors interpret findings for another, as the PSA example above shows. Research increasingly has to account for these overlaps rather than studying each issue in isolation.

The "good enough" problem. Existing pills and procedures already work reasonably well for most men, which paradoxically makes it harder to prove a genuinely new approach is worth adopting. Trials increasingly focus on speed of recovery, durability, and side-effect profiles rather than dramatic efficacy gains, since the efficacy bar set by current options is already fairly high.

The watchful-waiting problem. For men with mild symptoms, doing nothing but monitoring is a legitimate, evidence-based choice, not a failure to treat. This makes recruiting for early-intervention trials tricky, since a meaningful share of eligible men are, correctly, not being treated at all yet.

Does BPH affect more than urination?

For a lot of men, yes. Frequent nighttime bathroom trips disrupt sleep in ways that add up over time, and some BPH medications affect ejaculation or sexual function, which can be an unwelcome surprise if no one mentions it upfront. None of this is universal, and it's not a reason to avoid treatment, it's a reason to ask your doctor directly what side effects a specific option carries before starting it.

Common myths, cleared up

"An enlarged prostate always needs treatment."

Mild symptoms that aren't bothering you much can often be safely monitored rather than treated, a strategy doctors call watchful waiting.

"BPH medication and cancer screening are unrelated."

As the PSA section above shows, they can interact directly, which is exactly why your doctor needs your full medication list before ordering or interpreting a PSA test.

"If one BPH pill doesn't work, none will."

Alpha-blockers and 5-alpha-reductase inhibitors work through completely different mechanisms and on different timelines, so a poor response to one doesn't predict how you'll respond to the other, or to a combination of both.

How to find a BPH study through our platform

Search current studies by whether you're looking at medication, a specific in-office procedure, or a comparison between approaches, since eligibility and time commitment differ a lot across these categories. For example, one trial is testing a TNF blocker for BPH symptoms, another is studying Sonablate HIFU, a heat-based in-office procedure, and a third is directly comparing medication against the UroLift procedure to see which works better for which patients. Our BPH clinical trials page shows current recruiting studies. Applying takes about 5 minutes, and a coordinator follows up to confirm fit

Common questions

Can I take tadalafil for BPH if I don't have erectile dysfunction? Yes, it's approved as a BPH treatment on its own, separate from its ED approval, though your doctor will still consider your full health picture, including blood pressure medications, before prescribing it.

Does treating BPH lower my risk of prostate cancer? No, BPH and prostate cancer are separate conditions with separate causes, and treating one doesn't prevent or treat the other. Screening for cancer stays a separate conversation with your doctor.

If I choose watchful waiting now, can I still start treatment later? Yes. Watchful waiting isn't a one-time decision, it's an ongoing choice you and your doctor revisit as symptoms change, and you can move to medication or a procedure whenever it makes sense for you.

What are the symptoms of BPH? Common symptoms include a weak urine stream, needing to urinate often (especially at night), trouble starting or fully emptying the bladder, and a sudden urge to go. Symptoms tend to build up slowly over years rather than appearing all at once.

Is BPH the same as prostate cancer? No. BPH is a noncancerous enlargement of the prostate, while prostate cancer is a different condition entirely. They can cause similar urinary symptoms, which is why doctors often check for both, but having BPH doesn't mean you have or will develop prostate cancer.

What causes BPH? The exact cause isn't fully understood, but it's closely tied to age and hormonal changes that happen as men get older. It's extremely common and isn't linked to anything a person did or didn't do.

See BPH clinical trials recruiting near you:

BPH Clinical Trials

Share this article on social media: